11:22 AM EST, 02/06/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were higher late Thursday morning, rising 0.68% to 1,391.74 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by accommodations booking company trivago (TRVG) and financial services company Banco Bilbao Vizcaya Argentaria ( BBVA ) , which advanced 7.1% and 4%, respectively. They were followed by internet advertising firm Criteo ( CRTO ) and pharmaceutical company Novo Nordisk ( NVO ) , which were up 3.1% and 2.5%, respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company DBV Technologies ( DBVT ) , which lost 3.7% and 2.4%, respectively. They were followed by medical device maker EDAP TMS (EDAP) and biotech firm BioNTech (BNTX), which dropped 2.3% and 1.7% respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company AstraZeneca ( AZN ) and biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which rose 4.5% and 2.9%, respectively. They were followed by financial services company Barclays ( JJCTF ) and biopharmaceutical company Akari Therapeutics ( AKTX ) , which were up 2.7% each.

The decliners from the UK and Ireland were led by biopharmaceutical companies TC Biopharm ( TCBP ) and Mereo BioPharma Group ( MREO ) , which fell 4.7% and 4.4%, respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and educational publisher Pearson (PSO), which were down 3.2% and 2.8%, respectively.